Recent studies indicate that P-SEP can be used to monitor clinical response to therapeutic interventions prior to obtaining culture results, confirming it as a more reliable biomarker than CRP and PCT in neonatal sepsis [1,26,27]. Here, CRP is linked to Neonatal sepsis.